Policy / regulatoryFeb 2026 · High confidence
Robert F. Kennedy Jr.
US HHS Secretary
Robert F. Kennedy Jr. is the US Secretary of Health and Human Services and the figurehead of the 'Make America Healthy Again' movement, which has embraced peptides as a cause. Speaking on the Joe Rogan Experience, he signaled that the FDA would move about 14 injectable peptides back toward looser compounding rules so consumers could access them from 'ethical suppliers.' His statements are the policy engine behind the 2026 peptide moment — though reclassification is not the same as FDA approval. Documented from news coverage.
Watch
Joe Rogan Experience #2461 - Robert F. Kennedy, Jr.
In their words
On the Joe Rogan Experience, said he expected the FDA to reclassify 'about 14' injectable peptides within 'a couple of weeks' to give consumers access from 'ethical suppliers.'
The stack — peptides they’ve named
~14 injectable peptides (policy)
Signaled the FDA would ease Category-2 compounding limits — a regulatory shift, not an approval or a safety finding.